Losartan Potassium Prices Trend and Forecast
North America
In the fourth quarter of 2022, Losartan Potassium prices decreased somewhat in North America compared to the previous quarter. The CFR New York prices dropped from USD 81200/MT to USD 81220/MT from October to December by 0.93%. As per the market players, the US domestic market ended the year on a downward note because the demand in the end-user pharmaceutical and healthcare sector weakened. Even as importers expressed that disruptions related to Covid-19 in China had potentially brought greater hardship, costs declined throughout US supply chains, alleviating inflationary pressures. However, the US supply chains became more flexible entering December as a result of lower shipping demand brought on by slower consumer spending and a reduction in manufacturing activity.
Asia- Pacific
During the fourth quarter of 2022, the prices of Losartan Potassium across the Asia Pacific region displayed a downward price trajectory. Between October and December, FOB Shanghai prices in China decreased from USD 65000/MT to USD 64800/ MT. Due to the closure of production facilities for the Golden Week, orders for Losartan Potassium for China’s API market slightly decreased during the first week of October. Domestic merchants encountered a lot of contradicting signals following a one-week holiday and the market’s reopening, which made it difficult for the players to keep up with the slow development seen in the downstream industries. Offtakes in the pharmaceutical sectors remained moderate in terms of demand throughout the quarter. Despite China’s steps to broaden relaxations in Covid-19 curbs in response to a massive protest outburst in late November, the market witnessed pessimistic sentiments. The manufacturers had slowed down their production and were mainly focused on selling off their stocks even at cheap rates due to the ongoing yearlong destocking season.
Europe
In Europe, the German market for Losartan Potassium followed the same pattern as North America and Asia. The CFR Hamburg prices were resolved at USD 74600/ MT in October and USD 74500/ MT in December, indicating a downward trend. Demand from the downstream pharmaceutical sector was higher in the first half of the quarter than in the second half due to the unexpected rise in coronavirus infections, which caused a decrease in orders. In terms of supply, market players had sufficient stocks with them to meet any immediate order. However, Germany’s annual inflation rate moderated in December, as observed from German CPI, which fell to 8.6% in December from 10% in November, measured according to EU-national standards. Also, Germany’s trade flows had resumed at a more significant level, but the market’s fundamentals remained weak, resulting in lower prices.
ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.
